METHODS: We conducted key informant interviews with MHS policymakers and advisers, program managers and providers who were affiliated with the MHS from March 2020 through December 2022. Key themes were derived using thematic analysis and open coding methods.
RESULTS: We conducted 28 interviews between December 2022 and March 2023. During the pandemic, the MHS collaborated with federal and local healthcare authorities and private sector entities through endeavours such as Operation Warp Speed. Lessons and recommendations for future pandemics were also identified, including investment in biosurveillance systems and integration of behavioural and social sciences.
CONCLUSIONS: The MHS rapidly established and fostered key partnerships with the public and private sectors during the COVID-19 pandemic. The pandemic experience showed that while the MHS is a useful resource for the nation, it also benefits from partnering with a variety of organizations, agencies and private companies. Continuing to develop these partnerships will be crucial for coordinated, effective responses to future pandemics.
方法:我们对MHS政策制定者和顾问进行了重要的线人访谈,从2020年3月到2022年12月隶属于MHS的项目经理和提供商。使用主题分析和开放编码方法得出关键主题。
结果:我们在2022年12月至2023年3月之间进行了28次访谈。大流行期间,MHS通过诸如“扭曲速度行动”之类的努力与联邦和地方医疗保健当局以及私营部门实体合作。还确定了未来大流行的经验教训和建议,包括对生物监测系统的投资以及行为和社会科学的整合。
结论:在COVID-19大流行期间,MHS迅速建立并促进了与公共和私营部门的关键伙伴关系。大流行的经验表明,虽然MHS是国家的有用资源,它还受益于与各种组织的合作,机构和私营公司。继续发展这些伙伴关系对于协调,有效应对未来的流行病。